Related Experiment Video
Updated: Jun 10, 2026

Expression, Purification, and Antimicrobial Activity of S100A12
Published on: May 13, 2017
Intracellular and Extracellular Effects of S100B in the Cardiovascular Response to Disease
James N Tsoporis1, Forough Mohammadzadeh, Thomas G Parker
1Division of Cardiology, Department of Medicine, Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada M5B 1W8.
Insights
S100B protein influences heart attack recovery. While it can worsen cell death, reducing S100B may protect the heart and blood vessels.
Area of Science:
- Biochemistry
- Cardiology
- Molecular Biology
Background:
- S100B is a calcium-binding protein with intracellular and extracellular roles.
- S100B expression increases in the heart after myocardial infarction.
- Its dual functions present potential therapeutic targets for cardiovascular diseases.
Purpose of the Study:
- To investigate the role of S100B in cardiac and vascular responses, particularly after myocardial infarction.
- To explore the mechanisms underlying S100B's effects on cardiac hypertrophy, apoptosis, and vascular smooth muscle cell function.
- To assess the therapeutic potential of targeting S100B in cardiovascular diseases.
Main Methods:
- Studied S100B expression in human and rat myocardial infarction models.
- Utilized neonatal rat myocyte cultures and transgenic mice for forced S100B expression.
- Investigated S100B knockout effects on cardiac function and smooth muscle cell behavior.
- Examined extracellular S100B mechanisms involving the receptor for advanced glycation end products (RAGE) and downstream signaling pathways (ERK1/2, p53).
Main Results:
- Overexpressing S100B inhibited cardiac hypertrophy but increased myocyte apoptosis post-myocardial infarction.
- Knocking out S100B augmented hypertrophy, reduced apoptosis, and preserved cardiac function.
- S100B expression in aortic smooth muscle cells inhibited proliferation and response to adrenergic stimulation.
- Extracellular S100B induced apoptosis via RAGE, activating ERK1/2 and p53 signaling.
Conclusions:
- S100B plays a complex, context-dependent role in cardiovascular pathophysiology.
- Modulating S100B activity offers a promising therapeutic strategy for myocardial infarction and vascular diseases.
- Targeting both intracellular and extracellular functions of S100B could be beneficial for treating cardiac and vascular conditions.
Abstract:
S100B, a calcium-binding protein of the EF-hand type, exerts both intracellular and extracellular functions. S100B is induced in the myocardium of human subjects and an experimental rat model following myocardial infarction. Forced expression of S100B in neonatal rat myocyte cultures and high level expression of S100B in transgenic mice hearts inhibit cardiac hypertrophy and the associated phenotype but augments myocyte apoptosis following myocardial infarction. By contrast, knocking out S100B, augments hypertrophy, decreases apoptosis and preserves cardiac function following myocardial infarction. Expression of S100B in aortic smooth muscle cells inhibits cell proliferation and the vascular response to adrenergic stimulation. S100B induces apoptosis by an extracellular mechanism via interaction with the receptor for advanced glycation end products and activating ERK1/2 and p53 signaling. The intracellular and extracellular roles of S100B are attractive therapeutic targets for the treatment of both cardiac and vascular diseases.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Inflammation III: Local and Systemic Effects
Inflammatory Response I: Vascular and Cellular
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Paracrine Signaling

